In this section of the EURETINA IME video interview series on dry AMD & GA, Prof. Frank G. Holz and Dr. Arshad Khanani explore emerging complement pathway-targeting treatments for GA. They discuss key aspects, including patient selection, integrating these treatments into the GA patient workflow, and effectively communicating potential side effects. Prof. Holz and Dr. Khanani also address rare adverse events and provide recommendations on how to avoid or manage them. Finally, they share valuable real-world insights on the use of these therapies. Make sure to watch the other two videos in this series!